Kim; Dooseop

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kim; Dooseop.The latest application filed is for "beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes".

Company Profile

1.35.27

Kim; Dooseop - Eunpyung-gu KR
Kim; Dooseop - Seoul N/A KR
Kim; Dooseop - Westfield NJ
Kim; Dooseop - Scotch Plains NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Beta-amino Heterocyclic Dipeptidyl Peptidase Inhibitors For The Treatment Or Prevention Of Diabetes App 20200206221 - Edmondson; Scott D. ; et al.	2020-07-02
Inhibitors of the renal outer medullary potassim channel Grant 10,000,484 - Chobanian , et al. June 19, 2	2018-06-19
Beta-amino Heterocyclic Dipeptidyl Peptidase Inhibitors For The Treatment Or Prevention Of Diabetes App 20170348309 - Edmondson; Scott D. ; et al.	2017-12-07
Inhibitors of the renal outer medullary potassium channel Grant 9,777,002 - Walsh , et al. October 3, 2	2017-10-03
Inhibitors of the renal outer medullary potassium channel Grant 9,527,830 - Walsh , et al. December 27, 2	2016-12-27
Inhibitors Of The Renal Outer Medullary Potassim Channel App 20160304515 - Chobanian; Harry ; et al.	2016-10-20
Compounds as inhibitors of diacylglycerol O-acyltransferase type 1 enzyme Grant 9,271,969 - Kim , et al. March 1, 2	2016-03-01
Beta-amino Heterocyclic Dipeptidyl Peptidase Inhibitors For The Treatment Or Prevention Of Diabetes App 20150359793 - Edmondson; Scott D. ; et al.	2015-12-17
Inhibitors of the Renal Outer Medullary Potassium Channel App 20150299198 - Walsh; Shawn P. ; et al.	2015-10-22
Inhibitors of the renal outer medullary potassium channel Grant 9,062,070 - Pasternak , et al. June 23, 2	2015-06-23
Inhibitors of the renal outer medullary potassium channel Grant 9,056,859 - Pasternak , et al. June 16, 2	2015-06-16
Compounds As Inhibitors Of Diacylglycerol O-acyltransferase Type I Enzyme App 20150157611 - Kim; Dooseop ; et al.	2015-06-11
Inhibitors of the Renal Outer Medullary Potassium Channel App 20140206618 - Pasternak; Alexander ; et al.	2014-07-24
Beta-amino Heterocyclic Dipeptidyl Peptidase Inhibitors For The Treatment Or Prevention Of Diabetes App 20130217695 - Edmondson; Scott D. ; et al.	2013-08-22
Inhibitors of the Renal Outer Medullary Potassium Channel App 20130217680 - Pasternak; Alexander ; et al.	2013-08-22
CETP inhibitors derived from benzoxazole arylamides Grant 8,445,480 - Hunt , et al. May 21, 2	2013-05-21
Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of type 2 diabetes Grant 8,440,668 - Edmondson , et al. May 14, 2	2013-05-14
Antidiabetic tricyclic compounds Grant 8,399,507 - Liang , et al. March 19, 2	2013-03-19
CETP inhibitors Grant 8,334,290 - Ali , et al. December 18, 2	2012-12-18
Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of diabetes Grant 8,168,637 - Edmondson , et al. May 1, 2	2012-05-01
Novel Cyclic Azabenzimidazole Derivatives Useful As Anti-diabetic Agents App 20110190308 - Edmondson; Scott D. ; et al.	2011-08-04
Cetp Inhibitors Derived From Benzoxazole Arylamides App 20100298288 - HUNT; Julianne A. ; et al.	2010-11-25
Antidiabetic Tricyclic Compounds App 20100216694 - Liang; Gui-Bai ; et al.	2010-08-26
Beta-amino Heterocyclic Dipeptidyl Peptidase Inhibitors For The Treatment Or Prevention Of Diabetes App 20100130504 - Edmondson; Scott D. ; et al.	2010-05-27
Cetp Inhibitors App 20090264405 - Ali; Amjad ; et al.	2009-10-22
Beta-amino heterocyclic dipeptidyl peptidase inhibitors for diabetes Grant 7,390,809 - Kim , et al. June 24, 2	2008-06-24
.beta.-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes Grant 7,307,164 - Brockunier , et al. December 11, 2	2007-12-11
Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes App 20060270679 - Edmondson; Scott D. ; et al.	2006-11-30
Beta-amino tetrahydroimidazo (1, 2-a) pyrazines and tetrahydrotrioazolo (4, 3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes Grant 7,125,873 - Edmondson , et al. October 24, 2	2006-10-24
Pyrrolidine modulators of CCR5 chemokine receptor activity Grant 7,125,887 - Hale , et al. October 24, 2	2006-10-24
3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes App 20060052382 - Duffy; JosephL ; et al.	2006-03-09
Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes App 20060014953 - Kim; Dooseop ; et al.	2006-01-19
Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes App 20050107390 - Brockunier, Linda L. ; et al.	2005-05-19
Beta-amino tetrahydroimidazo (1, 2-a) pyrazines and tetrahydrotrioazolo (4,3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes App 20040167133 - Edmondson, Scott D. ; et al.	2004-08-26
Pyrrolidine modulators of ccr5 chemokine receptor activity App 20040087552 - Hale, Jeffrey J ; et al.	2004-05-06
Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes Grant 6,699,871 - Edmondson , et al. March 2, 2	2004-03-02
Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes App 20030100563 - Edmondson, Scott D. ; et al.	2003-05-29
Pyrrolidine modulators of chemokine receptor activity Grant 6,498,161 - Caldwell , et al. December 24, 2	2002-12-24
Cyclic amine modulators of chemokine receptor activity Grant 6,476,054 - Caldwell , et al. November 5, 2	2002-11-05
N-cyclopentyl modulators of chemokine receptor activity App 20020120146 - Finke, Paul E. ; et al.	2002-08-29
Pyrrolidine modulators of CCR5 chemokine receptor activity App 20020094989 - Hale, Jeffrey J. ; et al.	2002-07-18
N-cyclopentyl modulators of chemokine receptor activity Grant 6,358,979 - Finke , et al. March 19, 2	2002-03-19
Cyclic amine modulators of chemokine receptor activity Grant 6,140,349 - Caldwell , et al. October 31, 2	2000-10-31
Substituted pyridyl pyrroles, compositions containing such compounds and methods of use Grant 5,776,954 - de Laszlo , et al. July 7, 1	1998-07-07
Steroidal glycosides as antihyperlipidemic agents Grant 5,698,527 - Kim December 16, 1	1997-12-16
Heterocyclic compounds bearing acidic functional groups as angiotensin II antagonists Grant 5,412,097 - Chakravarty , et al. May 2, 1	1995-05-02
Substituted 1,2,4-triazoles bearing acidic functional groups as angiotensin II antagonists Grant 5,281,614 - Ashton , et al. January 25, 1	1994-01-25
Substituted quinazolinones bearing acidic functional groups as angiotensin II antagonists Grant 5,238,942 - Chakravarty , et al. August 24, 1	1993-08-24
Substituted pyrimidinones bearing acidic functional groups as angiotensin II antagonists Grant 5,223,501 - Chakravarty , et al. * June 29, 1	1993-06-29
6-amino substituted imidazo[4,5-bipyridines as angiotensin II antagonists Grant 5,223,499 - Greenlee , et al. June 29, 1	1993-06-29
Substituted 1-(2H)-isoquinolinones bearing acidic functional groups as angiotensin II antagonists Grant 5,162,340 - Chakravarty , et al. November 10, 1	1992-11-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.